A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetrators

The antifungal ketoconazole, which is mainly used for dermal infections and treatment of Cushing’s syndrome, is prone to drug-food interactions (DFIs) and is well known for its strong drug-drug interaction (DDI) potential. Some of ketoconazole’s potent inhibitory activity can be attributed to its me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Marok, Fatima (VerfasserIn) , Wojtyniak, Jan-Georg (VerfasserIn) , Fuhr, Laura Maria (VerfasserIn) , Selzer, Dominik (VerfasserIn) , Schwab, Matthias (VerfasserIn) , Weiß, Johanna (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Lehr, Thorsten (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 February 2023
In: Pharmaceutics
Year: 2023, Jahrgang: 15, Heft: 2, Pages: 1-22
ISSN:1999-4923
DOI:10.3390/pharmaceutics15020679
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/pharmaceutics15020679
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1999-4923/15/2/679
Volltext
Verfasserangaben:Fatima Zahra Marok, Jan-Georg Wojtyniak, Laura Maria Fuhr, Dominik Selzer, Matthias Schwab, Johanna Weiss, Walter Emil Haefel and Thorsten Lehr

MARC

LEADER 00000caa a2200000 c 4500
001 1844655628
003 DE-627
005 20250112235717.0
007 cr uuu---uuuuu
008 230505s2023 xx |||||o 00| ||eng c
024 7 |a 10.3390/pharmaceutics15020679  |2 doi 
035 |a (DE-627)1844655628 
035 |a (DE-599)KXP1844655628 
035 |a (OCoLC)1389530322 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Marok, Fatima  |e VerfasserIn  |0 (DE-588)1312176245  |0 (DE-627)1871924812  |4 aut 
245 1 2 |a A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetrators  |c Fatima Zahra Marok, Jan-Georg Wojtyniak, Laura Maria Fuhr, Dominik Selzer, Matthias Schwab, Johanna Weiss, Walter Emil Haefel and Thorsten Lehr 
264 1 |c 17 February 2023 
300 |a 22 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.12.2023 
520 |a The antifungal ketoconazole, which is mainly used for dermal infections and treatment of Cushing’s syndrome, is prone to drug-food interactions (DFIs) and is well known for its strong drug-drug interaction (DDI) potential. Some of ketoconazole’s potent inhibitory activity can be attributed to its metabolites that predominantly accumulate in the liver. This work aimed to develop a whole-body physiologically based pharmacokinetic (PBPK) model of ketoconazole and its metabolites for fasted and fed states and to investigate the impact of ketoconazole’s metabolites on its DDI potential. ... 
650 4 |a cytochrome P450 3A4 (CYP3A4) 
650 4 |a drug-drug interaction 
650 4 |a drug-food interaction 
650 4 |a ketoconazole 
650 4 |a metabolites 
650 4 |a P-glycoprotein (P-gp) 
650 4 |a physiologically based pharmacokinetic (PBPK) modeling 
650 4 |a reversible inhibition 
700 1 |a Wojtyniak, Jan-Georg  |e VerfasserIn  |4 aut 
700 1 |a Fuhr, Laura Maria  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Selzer, Dominik  |d 1983-  |e VerfasserIn  |0 (DE-588)117079016X  |0 (DE-627)104006728X  |0 (DE-576)512647798  |4 aut 
700 1 |a Schwab, Matthias  |d 1963-  |e VerfasserIn  |0 (DE-588)129154059  |0 (DE-627)390023604  |0 (DE-576)187446806  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |8 2\p  |a Lehr, Thorsten  |d 1977-  |e VerfasserIn  |0 (DE-588)132457830  |0 (DE-627)69060050X  |0 (DE-576)299158802  |4 aut 
773 0 8 |i Enthalten in  |t Pharmaceutics  |d Basel : MDPI, 2009  |g 15(2023), 2, Artikel-ID 679, Seite 1-22  |h Online-Ressource  |w (DE-627)614096529  |w (DE-600)2527217-2  |w (DE-576)313958653  |x 1999-4923  |7 nnas  |a A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetrators 
773 1 8 |g volume:15  |g year:2023  |g number:2  |g elocationid:679  |g pages:1-22  |g extent:22  |a A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetrators 
856 4 0 |u https://doi.org/10.3390/pharmaceutics15020679  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1999-4923/15/2/679  |x Verlag  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20230505 
993 |a Article 
994 |a 2023 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |d 50000  |e 910000PW1050230906  |e 910100PW1050230906  |e 50000PW1050230906  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
999 |a KXP-PPN1844655628  |e 4318183564 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetrators","title":"A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetrators"}],"person":[{"display":"Marok, Fatima","roleDisplay":"VerfasserIn","role":"aut","given":"Fatima","family":"Marok"},{"given":"Jan-Georg","roleDisplay":"VerfasserIn","role":"aut","display":"Wojtyniak, Jan-Georg","family":"Wojtyniak"},{"display":"Fuhr, Laura Maria","given":"Laura Maria","roleDisplay":"VerfasserIn","role":"aut","family":"Fuhr"},{"family":"Selzer","display":"Selzer, Dominik","given":"Dominik","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Schwab, Matthias","given":"Matthias","roleDisplay":"VerfasserIn","role":"aut","family":"Schwab"},{"display":"Weiß, Johanna","given":"Johanna","role":"aut","roleDisplay":"VerfasserIn","family":"Weiß"},{"family":"Haefeli","given":"Walter E.","roleDisplay":"VerfasserIn","role":"aut","display":"Haefeli, Walter E."},{"family":"Lehr","given":"Thorsten","roleDisplay":"VerfasserIn","role":"aut","display":"Lehr, Thorsten"}],"language":["eng"],"id":{"eki":["1844655628"],"doi":["10.3390/pharmaceutics15020679"]},"name":{"displayForm":["Fatima Zahra Marok, Jan-Georg Wojtyniak, Laura Maria Fuhr, Dominik Selzer, Matthias Schwab, Johanna Weiss, Walter Emil Haefel and Thorsten Lehr"]},"physDesc":[{"extent":"22 S."}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"17 February 2023"}],"relHost":[{"title":[{"title_sort":"Pharmaceutics","title":"Pharmaceutics"}],"disp":"A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetratorsPharmaceutics","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2009-"}],"name":{"displayForm":["Molecular Diversity Preservation International"]},"id":{"issn":["1999-4923"],"zdb":["2527217-2"],"eki":["614096529"]},"note":["Gesehen am 28.05.14"],"part":{"pages":"1-22","year":"2023","extent":"22","text":"15(2023), 2, Artikel-ID 679, Seite 1-22","issue":"2","volume":"15"},"recId":"614096529","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2009 -"]}],"note":["Gesehen am 05.12.2023"],"recId":"1844655628","type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a MAROKFATIMPHYSIOLOGI1720